🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07271745
Starting soon Observational

Multicenter Study on Early Arterial Changes in Prediabetic Patients Evaluated by Ultra-High-Frequency Ultrasound

NCT07271745 · tracked via the Priya Life Science China tracker
Sponsor
Chunyan Ma
Phase
Observational
Started
2025-12-15
Last updated
2025-12-09

Condition(s) studied

Prediabetes

Study summary

Ultra-high frequency ultrasound technology (20-100 MHz) can clearly distinguish the arterial intima and media layers, and can simultaneously meet the needs of examining the carotid artery and peripheral arteries, enabling earlier and more accurate detection of vascular damage in pre-diabetic individuals. Therefore, this study aims to establish the normal values of arterial intima and media thickness measured by ultra-high frequency ultrasound in healthy Chinese adults, providing quantitative reference for the early diagnosis, severity assessment, and efficacy observation of arterial diseases. Meanwhile, by applying ultra-high frequency ultrasound, this study intends to clarify the changes in arterial intima and media thickness in pre-diabetic populations and explore the influencing factors, so as to provide reference for the early prevention, diagnosis, and treatment of pre-diabetes and cardiovascular complications.

Eligibility

Sex
ALL
Min age
18 Years
Max age
79 Years
Healthy volunteers
Accepted
Prediabetic Patients Inclusion Criteria: * Impaired fasting glucose (venous plasma glucose ≥6.1 mmol/L, \<7.0 mmol/L, and \<7.8 mmol/L 2 hours after glucose loading); and/or Impaired glucose tolerance (venous plasma glucose \<7.0 mmol/L, and ≥7.8 mmol/L, \<11.1 mmol/L 2 hours after glucose loading). * Age ≥ 18 years old; * Normal blood pressure (139-90/89-60 mmHg); * Body mass index (BMI) \< 30 kg/m²; * Normal results in routine blood tests, fasting blood glucose, lipid profile, liver and kidney function tests, and electrocardiogram (ECG); * No history of cardiovascular diseases, diabetes, rheumatic connective tissue diseases, or severe liver/kidney dysfunction; * No history of acrocyanosis, no discomfort under cold stimulation, and no previous Raynaud's phenomenon in any part of the body; * No history of taking medications that affect the cardiovascular system. Exclusion Criteria : * Patients with hypertension, diabetes mellitus, hyperthyroidism, arrhythmia, etc. * Patients with connective tissue diseases such as systemic lupus erythematosus, polymyositis, rheumatoid arthritis, etc. * History of blood diseases, severe infections, or other systemic diseases. * Administration of vasoactive drugs within the past month. * Peripheral vascular diseases with arterial occlusion that prevents detection of blood flow signals. * Inability to cooperate with the examination.

Primary outcome measure(s)

Trial sites (30)

FacilityCityRegionStatus
Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou Guangdong
The First Affiliated Hospital of Sun Yat-sen University Guangzhou Guangdong
The First Affiliated Hospital of Guangxi University of Chinese Medicine Nanning Guangxi
The First Affiliated Hospital of Heilongjiang University of Chinese Medicine Harbin Heilongjiang
The Second Affiliated Hospital of Harbin Medical University Harbin Heilongjiang
The Second Hospital of Heilongjiang Province Harbin Heilongjiang
Jiamusi Central Hospital, Heilongjiang Province Jiamusi Heilongjiang
Henan Provincial People's Hospital Zhengzhou Henan
Jiangsu Provincial People's Hospital Nanjing Jiangsu
The Second Affiliated Hospital of Nanchang University Nanchang Jiangxi
China-Japan Union Hospital of Jilin University Changchun Jinlin
The First Hospital of Jilin University Changchun Jinlin
Anshan Central Hospital Anshan Liaoning
Chaoyang Central Hospital Chaoyang Liaoning
The First Affiliated Hospital of Dalian Medical University Dalian Liaoning
The Affiliated Hospital of Liaoning University of Traditional Chinese Medicine Shenyang Liaoning
Tongliao People's Hospital of Inner Mongolia Autonomous Region Tongliao Neimenggu
Qilu Hospital (Qingdao Branch) of Shandong University Qingdao Shandong
West China Hospital,Sichuan University Chengdu Sichuan
The First Affiliated Hospital of Kunming Medical University Kunming Yunnan
The First People's Hospital of Yunnan Province Kunming Yunnan
The Third People's Hospital of Yunnan Province Kunming Yunnan
The Second People's Hospital of Qujing City Qujing Yunnan
Li Huili Hospital of Ningbo Medical Center, Zhejiang Province Ningbo Zhejing
Beijing Hospital Beijing China
Beijing Tiantan Hospital, Capital Medical University Beijing China
Jiading District Central Hospital of Shanghai Municipality Shanghai China
Renji Hospital, Shanghai Jiao Tong University School of Medicine Shanghai China
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Affiliated to Shanghai University of Traditional Chinese Medicine Shanghai China
The Third Central Hospital of Tianjin Tianjin China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07271745 on ClinicalTrials.gov ↗ ← All trials in China